文献速递衰弱、肌少症与跌倒

表观遗传年龄加速与MOBILIZE波士顿队列衰弱变化的关系

Epigenetic Age Acceleration and Change in Frailty in MOBILIZE Boston.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2022-01-01

基线衰弱评分与PhenoAge及GrimAge eAA相关,基线衰弱指数与外源性、GrimAge和PhenoAge eAA相关,但任何eAA指标均与衰弱变化无关。

要点

  • 基线衰弱评分与PhenoAge和GrimAge eAA相关,与内在/外在eAA无关。
  • 基线衰弱指数与外源性、GrimAge和PhenoAge eAA相关。
  • 所有eAA指标均与12-18个月衰弱变化无关。

核心结论

  • 在MOBILIZE波士顿队列中,任何表观遗传年龄加速指标均与衰弱变化无关。

研究设计与样本

  • MOBILIZE波士顿队列研究,参与者间隔12-18个月进行两次评估。
  • 基线全血DNA甲基化用Infinium 450k阵列检测,计算内在、外在、GrimAge和PhenoAge eAA。
  • 衰弱用基于衰弱表型的连续衰弱评分和衰弱指数评估,分析采用相关和线性回归,调整年龄、性别、吸烟状态和体重指数。

主要发现

  • 基线衰弱评分与内在或外在eAA不相关,但与PhenoAge相关,调整协变量后仍与GrimAge相关。
  • 基线衰弱指数与外源性、GrimAge和PhenoAge eAA相关,无论是否调整协变量。
  • 任何eAA指标均与衰弱变化无关,无论是否调整协变量。

临床怎么用

  • 目前证据不支持将表观遗传年龄加速作为预测12-18个月内衰弱变化的生物标志物。

局限性

  • 随访时间较短(12-18个月),可能不足以观察衰弱变化。
  • 仅使用基线eAA测量,未重复测量表观遗传年龄加速。
  • 所有有表观遗传数据的参与者均为白人,限制普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Age-associated changes in DNA methylation have been implicated as 1 mechanism to explain the development of frailty; however, previous cross-sectional studies of epigenetic age acceleration (eAA) and frailty have had inconsistent findings. Few longitudinal studies have considered the association of eAA with change in frailty. We sought to determine the association between eAA and change in frailty in the MOBILIZE Boston cohort. Participants were assessed at 2 visits 12-18 months apart. Intrinsic, extrinsic, GrimAge, and PhenoAge eAA were assessed from whole-blood DNA methylation at baseline using the Infinium 450k array. Frailty was assessed by a continuous frailty score based on the frailty phenotype and by frailty index (FI). Analysis was by correlation and linear regression with adjustment for age, sex, smoking status, and body mass index. Three hundred and ninety-five participants with a frailty score and 431 with an FI had epigenetic and follow-up frailty measures. Mean (standard deviation) ages were 77.8 (5.49) and 77.9 (5.47) for the frailty score and the FI cohorts respectively, and 232 (58.7%) and 257 (59.6%) were female. All participants with epigenetic data identified as White. Baseline frailty score was not correlated with intrinsic or extrinsic eAA, but was correlated with PhenoAge and, even after adjustment for covariates, GrimAge. Baseline FI was correlated with extrinsic, GrimAge, and PhenoAge eAA with and without adjustment. No eAA measure was associated with change in frailty, with or without adjustment. Our results suggest that no eAA measure was associated with change in frailty. Further studies should consider longer periods of follow-up and repeated eAA measurement.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Seligman BJ, Berry SD, Lipsitz LA, et al. Epigenetic Age Acceleration and Change in Frailty in MOBILIZE Boston. J Gerontol A Biol Sci Med Sci. 2022. PMID: 35037036. doi:10.1093/gerona/glac019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。